Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2011

Oct 18, 2011

29777_dirs_2011-10-18_acca1ecd-475e-434e-93a7-4b27f0d25e1d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-10-15

Reporting Person: ALBAN CARLOS (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-10-15 Common shares without par value A 4900 Acquired 95306 Direct
2011-10-15 Common shares without par value F 2032 $52.73 Disposed 93274 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 672 Indirect
Common shares without par value 137 Indirect

Footnotes

F1: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of October 17, 2011.